Awards are available for successful applicants from LMICs to cover the cost of their travel, accommodation and single-entry visa.
Meeting
summary:
Artificial
intelligence (AI) is increasingly being used in global health research but
frameworks, policy and best practice for the ethical review and oversight of
AI-enabled studies is currently lacking. The Forum will discuss how traditional
research ethics regulatory frameworks have responded to the rapid advances in
AI technology, and what changes are required, including to the role and
responsibility of research ethics committees (RECs). It will explore the
ethical challenges such as bias, privacy, data provenance and ownership,
along with the need for transparency, accountability and engagement during the
design and use of AI in global health research. To date, these discussions have
predominantly taken place in high-income countries, and low- and middle-income
country (LMIC) perspectives have been underrepresented. The Forum will
consider the LMIC context where AI has the potential to address critical
skills shortages and improve access to care, but where the ethical
challenges are made harder due to existing disparities in infrastructure,
knowledge and capacity. The Forum will take
a multidisciplinary approach to explore how AI technology is being designed and
used in health research, reflecting the range of actors involved in
this space and the importance of computer scientists and technologists who
apply AI for health to understand research ethics frameworks and
considerations.
As
part of the upcoming meeting, the GFBR is seeking case studies that bring attention to key ethical
issues that have emerged regarding the use of AI in health research in
LMIC settings and proposals to participate in a session on governance
issues. The GFBR is also seeking participants to
attend the meeting, with places awarded on a competitive basis.
Full
details on how to apply are available on the GFBR website and the background paper provides further details on the meeting theme.
The deadline for
applications is 17.00 CET on 17 June 2022.
EDCTP Career Development Fellow Dr Virginie Rozot, a research officer at the South African Tuberculosis Vaccine Initiative (SATVI), has been awarded a multi‑year contract under Wellcome Leap’s Delta Tissue (∆T) programme. Her research will investigate how the human immune system responds to Mycobacterium tuberculosis in the thoracic lymph nodes, and why these responses sometimes fail, allowing the bacteria to spread to other organs. The findings are expected to inform future TB vaccine design and vaccination strategies.
Global Health EDCTP3 is now inviting applications for the EDCTP Prizes 2027, recognising outstanding individuals and research teams from Africa and Europe for their achievements in global health research and innovation.
The 2027 edition will award four prize categories, highlighting excellence in scientific leadership, collaborative team research, and gender-balanced scientific contributions. Prize winners will be announced at the EDCTP Forum 2027 in Madrid, Spain. Submissions are open until 2 September 2026.
Global Health EDCTP3 has opened the calls for abstracts, scientific symposia and workshops for the EDCTP Forum 2027, one of the leading global health research events focused on infectious diseases in sub-Saharan Africa. The deadline for submissions is 2 September 2026 at 17:00 (Brussels time).
Under the theme ‘Innovating together for resilient global health', the 13th edition of the EDCTP Forum, taking place from 5-9 April 2027 in Madrid, Spain, will offer researchers, policymakers, funders and implementers the opportunity to showcase their work at a flagship global health event.
The Forum offers a unique platform to share research findings, build partnerships and help shape discussions on global health priorities. Currently, submissions for abstracts, scientific symposia and workshops are open.